{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:51:56Z","timestamp":1789487516607,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"The Michael J Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"National Agency for Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xcrm.2026.102983","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:10:35Z","timestamp":1786547435000},"page":"102983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preclinical evaluation of nitrated \u03b1-synuclein-specific CAR-Treg therapy in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"7","author":[{"given":"Valentina","family":"Ugalde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Elgueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Chovar-Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Catenaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"\u00c1lvarez-Astudillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafne","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Sanchez-Guajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda In\u00e9s","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7692-8467","authenticated-orcid":false,"given":"Zulmary","family":"Manjarres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Lladser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheril","family":"Tapia-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Loyola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A.","family":"Quezada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roque","family":"Villagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8057-9806","authenticated-orcid":false,"given":"Rodrigo","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102983_bib1","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1093\/brain\/awae177","article-title":"The immune system in Parkinson's disease: what we know so far","volume":"147","author":"Roodveldt","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.xcrm.2026.102983_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12974-014-0201-8","article-title":"T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases","volume":"11","author":"Gonz\u00e1lez","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.xcrm.2026.102983_bib3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11481-015-9618-9","article-title":"Regulation of the Neurodegenerative Process Associated to Parkinson's Disease by CD4+ T-cells","volume":"10","author":"Gonz\u00e1lez","year":"2015","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102983_bib4","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102983_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001376","article-title":"Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons","volume":"3","author":"Benner","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.102983_bib6","article-title":"Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats","volume":"5","author":"Yu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.102983_bib7","first-page":"72","article-title":"T-cell based immunotherapies for Parkinson\u2019s disease","volume":"1","author":"Pacheco","year":"2021","journal-title":"Explor. Neuroprotective Ther."},{"key":"10.1016\/j.xcrm.2026.102983_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12974-016-0532-8","article-title":"alpha-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology","volume":"13","author":"Christiansen","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.xcrm.2026.102983_bib9","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","article-title":"Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease","volume":"184","author":"Reynolds","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102983_bib10","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson's disease recognize alpha-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102983_bib11","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1471-4159.2007.05087.x","article-title":"Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease","volume":"104","author":"Reynolds","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.xcrm.2026.102983_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11481-008-9100-z","article-title":"Nitrated alpha-synuclein and microglial neuroregulatory activities","volume":"3","author":"Reynolds","year":"2008","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102983_bib13","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.4049\/jimmunol.0803982","article-title":"Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets","volume":"182","author":"Reynolds","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102983_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.123","article-title":"IFN-gamma signaling, with the synergistic contribution of TNF-alpha, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease","volume":"3","author":"Barcia","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2026.102983_bib15","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.4049\/jimmunol.1203121","article-title":"Dopamine Receptor D3 Expressed on CD4+ T Cells Favors Neurodegeneration of Dopaminergic Neurons during Parkinson's Disease","volume":"190","author":"Gonz\u00e1lez","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102983_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.07.012","article-title":"Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases","volume":"274","author":"Gonz\u00e1lez","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.xcrm.2026.102983_bib17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-019-1405-y","article-title":"Intestinal infection triggers Parkinson's disease-like symptoms in Pink1(-\/-) mice","volume":"571","author":"Matheoud","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102983_bib18","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102983_bib19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbi.2022.01.007","article-title":"Neurodegeneration by alpha-synuclein-specific T cells in AAV-A53T-alpha-synuclein Parkinson's disease mice","volume":"101","author":"Karikari","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.xcrm.2026.102983_bib20","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awab103","article-title":"CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson disease","volume":"144","author":"Williams","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.xcrm.2026.102983_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-018-0824-5","article-title":"Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery","volume":"565","author":"Ito","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102983_bib22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/2159-8290.CD-12-0548","article-title":"The basic principles of chimeric antigen receptor design","volume":"3","author":"Sadelain","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102983_bib23","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1158\/1078-0432.CCR-11-1920","article-title":"The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer","volume":"18","author":"Lee","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102983_bib24","first-page":"e425","article-title":"Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation","volume":"24","author":"Wang","year":"2012","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.xcrm.2026.102983_bib25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nri3464","article-title":"The plasticity and stability of regulatory T cells","volume":"13","author":"Sakaguchi","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102983_bib26","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/hum.2008.188","article-title":"Highly efficient multicistronic lentiviral vectors with peptide 2A sequences","volume":"20","author":"Ibrahimi","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.xcrm.2026.102983_bib27","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.4049\/jimmunol.1502420","article-title":"Dopamine Receptor D3 Signaling on CD4+ T Cells Favors Th1- and Th17-Mediated Immunity","volume":"196","author":"Contreras","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102983_bib28","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","article-title":"Microglia clear neuron-released alpha-synuclein via selective autophagy and prevent neurodegeneration","volume":"11","author":"Choi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102983_bib29","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102983_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1124\/pharmrev.122.000674","article-title":"Regulation of Pain Perception by Microbiota in Parkinson Disease","volume":"76","author":"Manjarres","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.xcrm.2026.102983_bib31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11481-019-09888-5","article-title":"Treg Cells Attenuate Neuroinflammation and Protect Neurons in a Mouse Model of Parkinson's Disease","volume":"15","author":"Huang","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102983_bib32","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.21037\/apm-20-1096","article-title":"Effects and potential mechanisms of rapamycin on MPTP-induced acute Parkinson's disease in mice","volume":"10","author":"Zhang","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.xcrm.2026.102983_bib33","article-title":"Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease","volume":"8","author":"Zhang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2026.102983_bib34","first-page":"465","article-title":"[Neuroprotective effect of rapamycin against Parkinson's disease in mice]","volume":"47","author":"Zhu","year":"2018","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.xcrm.2026.102983_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2628","article-title":"Modeling Parkinson's disease-related symptoms in alpha-synuclein overexpressing mice","volume":"12","author":"Aniszewska","year":"2022","journal-title":"Brain Behav."},{"key":"10.1016\/j.xcrm.2026.102983_bib36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrn2652","article-title":"Tests to assess motor phenotype in mice: a user's guide","volume":"10","author":"Brooks","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.xcrm.2026.102983_bib37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/14712598.2021.1857361","article-title":"Lymphodepletion strategies to potentiate adoptive T-cell immunotherapy - what are we doing; where are we going?","volume":"21","author":"Bechman","year":"2021","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.xcrm.2026.102983_bib38","first-page":"3791","article-title":"Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human alpha-Synuclein","volume":"10","author":"Elgueta","year":"2022","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.xcrm.2026.102983_bib39","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/NEN.0b013e31829768d2","article-title":"alpha-Synuclein vaccination prevents the accumulation of parkinson disease-like pathologic inclusions in striatum in association with regulatory T cell recruitment in a rat model","volume":"72","author":"Sanchez-Guajardo","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.xcrm.2026.102983_bib40","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/mt.2014.41","article-title":"Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells","volume":"22","author":"Blat","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2026.102983_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00981","article-title":"Dopamine Receptor D3 Expression Is Altered in CD4+ T-Cells From Parkinson's Disease Patients and Its Pharmacologic Inhibition Attenuates the Motor Impairment in a Mouse Model","volume":"10","author":"Elgueta","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102983_bib42","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1038\/s41467-025-62478-3","article-title":"The spatial landscape of glial pathology and T cell response in Parkinson's disease substantia nigra","volume":"16","author":"Ma","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102983_bib43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jsps.2011.06.003","article-title":"Vaccine adjuvants - Current status and prospects on controlled release adjuvancity","volume":"19","author":"Sivakumar","year":"2011","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.xcrm.2026.102983_bib44","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1172\/JCI129208","article-title":"State of the art in CAR T cell therapy for CD19+ B cell malignancies","volume":"130","author":"Frigault","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102983_bib45","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12974-020-01888-0","article-title":"Neuroinflammation is associated with infiltration of T cells in Lewy body disease and alpha-synuclein transgenic models","volume":"17","author":"Iba","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.xcrm.2026.102983_bib46","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12974-016-0632-5","article-title":"Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model","volume":"13","author":"Sommer","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.xcrm.2026.102983_bib47","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.xcrm.2026.102983_bib48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/hyb.1998.17.373","article-title":"Development of monoclonal antibodies to gizzerosine, a toxic component present in fish meal","volume":"17","author":"Becker","year":"1998","journal-title":"Hybridoma"},{"key":"10.1016\/j.xcrm.2026.102983_bib49","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102983_bib50","doi-asserted-by":"crossref","first-page":"7647","DOI":"10.4049\/jimmunol.173.12.7647","article-title":"T cell activation by antibody-like immunoreceptors: increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity","volume":"173","author":"Chmielewski","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102983_bib51","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.xcrm.2026.102983_bib52","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12974-019-1652-8","article-title":"Dopamine receptor D3 signalling in astrocytes promotes neuroinflammation","volume":"16","author":"Montoya","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.xcrm.2026.102983_bib53","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","article-title":"Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein","volume":"24","author":"Fleming","year":"2004","journal-title":"J. Neurosci."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:48:21Z","timestamp":1789483701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126004003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666379126004003"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102983","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical evaluation of nitrated \u03b1-synuclein-specific CAR-Treg therapy in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102983"}}